Pembrolizumab-Induced Cold Agglutinin Disease

Osman Atiq1, Saad O Atiq2, Zainab O Atiq3

  • 1Department of Internal Medicine, Unity Health, Searcy, AR, USA.

Summary

Pembrolizumab therapy for metastatic lung cancer can cause cold agglutinin disease (CAD), a rare autoimmune hemolytic anemia. Early diagnosis and treatment with Rituximab are crucial for recovery, as demonstrated in this case report.